Mpox can have a devastating impact on people with advanced cases of HIV, leading to severe skin and genital lesions and causing death in as many as 1 in 4 of those with a highly compromised immune ...

In a recent study published in The Lancet, researchers assessed the incidence of mpox in individuals with advanced human immunodeficiency virus (HIV) infection. In July 2022, the World Health ...

A global case series described a severe form of mpox linked to a 15% mortality rate among people living with HIV and low CD4 counts. An international network of clinicians have discovered a severe, ...

The incidence of skin diseases in people with HIV has declined significantly over the past decade, but some patient groups remain at a higher risk, particularly for cutaneous malignancies (CM), ...

The incidence of anal cancer is substantially higher among persons living with the human immunodeficiency virus (HIV) than in the general population. Similar to cervical cancer, anal cancer is ...

Challenges and Opportunities in the Treatment of Invasive Cervical Cancer in Low-Resource Settings: A Survey of the International Gynecologic Cancer Society Fellowship Programs We used existing data ...

Results from a national study led by UC San Francisco informed the first guidelines at the federal level in the U.S. to detect and treat anal cancer precursor lesions in people with HIV to reduce the ...

The first patient to have COVID-19, monkeypox, and HIV at the same time was recently diagnosed in Italy. He came down with a fever and sore throat, then a blistering rash, about a week after a trip to ...